In this interview with Plastic Surgery Practice , Joely Kaufman, MD, a board-certified dermatologist, fellow of the American Academy of Dermatology, and director of Skin Associates of South Florida in Coral Gables, discusses findings from the study, Survey of Facial Aesthetic Concerns and Treatment Trends Following GLP-1 Agonist-Associated Weight Loss , presented at the 2025 American Society for Dermatologic Surgery Annual Meeting, and shares how plastic surgeons and other aesthetic providers are adapting their treatment algorithms to address the unique facial changes associated with GLP-1related weight loss
Persistent cloudiness or visible particles may indicate contamination or degradation
[3] Dimeric copper peptide incorporated hydrogel for promoting diabetic wound healing
Originally developed for diabetes, then approved for obesity, and now showing promise for various psychiatric conditions including binge eating disorder, substance use disorders, and possibly depression itself
GLP-1 medicationsincluding GLP-1 agonists like semaglutide and dual agonists like tirzepatidework by targeting incretin pathways to reduce hunger, slow digestion, and improve blood sugar regulation
Fix the nutrition, and you address the primary mechanism
